Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06867068 · ClinicalTrials.gov registry record · Phase 1
Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery
A Phase 1 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 73
- Enrollment target
NCT06867068 is a Phase 1 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 73 participants.
The verdict
NCT06867068, a Phase 1 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this pilot study was to compare two commonly employed intravenous drug combinations; I) nitrous oxide, midazolam, fentanyl, and ketamine and II) the same combination with substitution of propofol for ketamine, for use during wisdom teeth extraction. Measures of recovery, amnesia testing 20 minutes after induction and after completion of recovery tests, patient satisfaction, and surgeon satisfaction will be evaluated. The data from this pilot study will be used to obtain preliminary estimates of effect sizes and to select primary and secondary endpoints for the design of a larger scale and more definitive trial of the two anesthetic approaches.
Interventions
- DRUG Ketamine
- DRUG Nitrous oxide
- DRUG Fentanyl
- DRUG Midazolam Hydrochloride
- DRUG Propofol injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2016-10-04 |
| Est. Completion | 2024-06-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06867068
The ClinicalTrials.gov registry entry for NCT06867068 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ketamine is the first listed.
NCT06867068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06867068 about?
NCT06867068 is a clinical study titled "Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery". The purpose of this pilot study was to compare two commonly employed intravenous drug combinations; I) nitrous oxide, midazolam, fentanyl, and ketamine and II) the same combination with substitution of propofol for ketamine, for use during wisdom teeth extraction. Measures of recovery, amnesia testi...
What is the current status of trial NCT06867068?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 73 participants. The study started on 2016-10-04. Estimated completion is 2024-06-10.
What interventions are being tested in trial NCT06867068?
The interventions under investigation include: Ketamine (DRUG), Nitrous oxide (DRUG), Fentanyl (DRUG), Midazolam Hydrochloride (DRUG), Propofol injection (DRUG).
Who is sponsoring clinical trial NCT06867068?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.